Palliative treatment for gynaecologic cancer. Ten years of experience in a regional hospital;Palliativ behandling ved gynekologisk kreft

Tidsskrift for den Norske Laegeforening

Volumn 121, Issue 16, 2001, Pages 1896-1901

  Onsrud, Mathias ^a,b   Hagen, Bjørn ^a   Heimstad, Runa ^a  

^a Gynekologisk Avd Regionsykehuset I   (Norway)

^b ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; FEMALE; HUMAN; INTESTINE OBSTRUCTION; LENGTH OF STAY; METHODOLOGY; MIDDLE AGED; MORTALITY; NORWAY; NURSING; OVARY TUMOR; PALLIATIVE THERAPY; RETROSPECTIVE STUDY; TERMINAL CARE; UTERUS CANCER; VULVA TUMOR;

ADULT; AGED; FEMALE; HOSPITAL MORTALITY; HUMANS; INTESTINAL OBSTRUCTION; LENGTH OF STAY; MIDDLE AGED; NORWAY; OVARIAN NEOPLASMS; PALLIATIVE CARE; RETROSPECTIVE STUDIES; TERMINAL CARE; UTERINE NEOPLASMS; VULVAR NEOPLASMS;

EID: 0035919440     PISSN: 00292001     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Norges offentlige utredninger. Livshjelp. Behandling, pleie og omsorg for uhelbredelig syke og døende. NOU 1999: 2. Oslo: Statens forvaltningstjeneste, Seksjon statens trykning, 1999.
2. Norges offentlige utredninger. Omsorg og kunnskap. Norsk kreftplan. NOU 1997: 20. Oslo: Statens forvaltningstjeneste, Seksjon statens trykning, 1997.
3. Baines MJ. The pathophysiology and management of malignant intestinal obstruction. I: Doyle E, Hanks GWC, MacDonald N, red. Palliative medicine. 2. utg. Oxford: Oxford University Press, 1998: 526-33.
4. Wist E. Palliativ kjemoterapi. I: Kaasa S, red. Palliativ behandling og pleie. Oslo: Ad Notam Gyldendal, 1998: 523-32.
5. Norges offisielle statistikk. Dødsårsaker 1996. Oslo: Statistisk sentralbyrå, 2000.
6. Kaasa S, Borchgrevink PC. Smertebehandling. I: Kaasa S, red. Palliativ behandling og pleie. Oslo: Ad Notam Gyldendal, 1998: 293-390.
7. Piver MS, Barlow JJ, Lele SB. Survival after ovarian cancer induced intestinal obstruction. Gynecol Oncol 1982; 13: 44-9.
8. Krebs HB, Goplerud DR. Surgical management of bowel obstruction in advanced ovarian carcinoma. Obstet Gynecol 1983; 61: 327-30.
9. Clarke-Pearson DL, Chin NO, DeLong ER. Surgical management of intestinal obstruction in ovarian cancer. Gynecol Oncol 1987; 26: 11-8.
10. Rubin SC, Hoskins WJ, Benjamin I. Palliative surgery for intestinal obstruction in advanced ovarian cancer. Gynecol Oncol 1989; 34: 16-9.
11. Lund B, Lundwall F, Hansen HH. Intestinal obstruction in patients with carcinoma of the ovaries treated with combination chemotherapy. Surg Gynecol Obstet 1989; 169: 213-8.
12. Bais JMJ, Schilthuis MS, Slors JFM, Lammes FB. Intestinal obstruction in patients with advanced ovarian cancer. Int J Gynecol Cancer 1995; 5: 346-50.
13. Hogan WM, Boente MP. The role of surgery in the management of recurrent gynecologic cancer. Semin Oncol 1993; 20: 462-72.
14. Berek JS, Tropé C, Vergote I. Surgery during chemotherapy and at relapse of ovarian cancer. Ann Oncol 1999; 10 (suppl): 3-7.
15. Baines M, Oliver DJ, Carter RL. Medical management of intestinal obstruction in patients with advanced malignant disease. Lancet 1985; 2: 990-3.
16. Ottesen S, Kaasa S. Kreft og fordøyelsesplager. Oslo: Den Norske Kreftforening, 1997.
17. Kaasa S. Malign obstruksjon av gastrointestinaltraktus. I: Kaasa S, red. Palliativ behandling og pleie. Oslo: Ad Notam Gyldendal, 1998: 495-505.
18. Halle JS, Rosenman JG, Varia MA, Fowler WC, Walton LA, Curie JL. 1000 cGy single dose palliation for advanced carcinoma of the cervix or endometrium. Int J Radial Oncol Biol Phys 1986; 12: 1947-50.
19. Onsrud M. Gynekologisk kreft. I: Kaasa S, Wist E, Høst H, red. Palliativ strålebehandling. Oslo: Universitetsforlaget, 1992: 155-63.
20. Tropé C, Marth C, Kaern J. Tamoxifen in the treatment of recurrent ovarian carcinoma. Eur J Cancer 2000; 36 (suppl): 59-61.
21. Kaasa S, Klepp O, Hagen S, Wist E, Kvinnsland S. Treatment intention in hospitalized cancer patients in oncological wards in Norway: a national survey. Cancer Treat Rev 1996; 22 (suppl A): 33-9.